Yaron Werber
Stock Analyst at TD Cowen
(0.90)
# 3,618
Out of 4,784 analysts
41
Total ratings
32.14%
Success rate
-20.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences | Initiates: Buy | n/a | $8.20 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $19.99 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $6.10 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $154.68 | -1.09% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $94.95 | +28.49% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $6.87 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $37.82 | +93.02% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $36.70 | -7.36% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $31.15 | +89.41% | 1 | Jul 23, 2024 | |
| LEGN Legend Biotech | Maintains: Buy | $71 → $67 | $35.06 | +91.10% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $7.21 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.46 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.64 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.95 | - | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $19.93 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $589.15 | +8.80% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.43 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $25 | $0.31 | +7,866.86% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.08 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $19.90 | +90.95% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.08 | - | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.16 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $10.38 | - | 1 | Oct 26, 2021 |
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $8.20
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $19.99
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $6.10
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $154.68
Upside: -1.09%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $94.95
Upside: +28.49%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $6.87
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $37.82
Upside: +93.02%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $36.70
Upside: -7.36%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $31.15
Upside: +89.41%
Legend Biotech
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $35.06
Upside: +91.10%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $7.21
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.46
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.64
Upside: -
Jan 31, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.95
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $19.93
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $589.15
Upside: +8.80%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $0.43
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $15 → $25
Current: $0.31
Upside: +7,866.86%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $18.08
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $19.90
Upside: +90.95%
Apr 6, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $4.08
Upside: -
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.16
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $10.38
Upside: -